CA AB1487

Limits HTLV testing requirement to tissues rich in viable leukocytes, rather than requiring it for all tissues.

Extends deadline for State Department of Public Health to adopt regulations on sperm processing facilities from January 1, 2010 to January 1, 2014.

Requires physicians to inform recipients of sperm from HIV or HTLV-reactive donors that they must establish an ongoing relationship with another physician for medical care during and after fertility treatment.

Removes requirement for physicians to provide prophylactic treatments and mandatory followup testing; instead requires physicians to recommend followup testing and document guidelines in the recipient's medical record.

Removes provision allowing use of sperm from HIV or HTLV-reactive donors if the recipient has also tested positive for the same infection; applies new provisions to all human T lymphotrophic viruses.